| scholarly article | Q13442814 |
| P356 | DOI | 10.2307/2532645 |
| P888 | JSTOR article ID | 2532645 |
| P698 | PubMed publication ID | 1742443 |
| P5875 | ResearchGate publication ID | 21414233 |
| P894 | zbMATH Open document ID | 0735.62100 |
| P2093 | author name string | Simon R | |
| Dixon DO | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | applied mathematics | Q33521 |
| Cox proportional hazards model | Q223218 | ||
| P6104 | maintained by WikiProject | WikiProject Mathematics | Q8487137 |
| P304 | page(s) | 871-881 | |
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | Biometrics | Q2025724 |
| P1476 | title | Bayesian Subset Analysis | |
| P478 | volume | 47 |
| Q38176069 | A Bayesian approach to subgroup identification |
| Q40462620 | A Bayesian model for evaluating specificity of treatment effects in clinical trials |
| Q38893729 | A Bayesian subgroup analysis using collections of ANOVA models |
| Q51615460 | A Bayesian subgroup analysis with a zero-enriched Polya Urn scheme. |
| Q30612579 | A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data |
| Q88887124 | A nonparametric Bayesian basket trial design |
| Q52653981 | A serious game for children with Attention Deficit Hyperactivity Disorder: Who benefits the most? |
| Q35776881 | A weighting approach for judging the effect of patient strata on high-dimensional risk prediction signatures |
| Q33650220 | Aggressive vs. conservative phototherapy for infants with extremely low birth weight |
| Q89855544 | Aim for Clinical Utility, Not Just Predictive Accuracy |
| Q52079395 | Approximate Bayesian evaluation of multiple treatment effects. |
| Q34485601 | Assessing Local Model Adequacy in Bayesian Hierarchical Models Using the Partitioned Deviance Information Criterion |
| Q37396643 | Bayesian analysis of heterogeneous treatment effects for patient-centered outcomes research. |
| Q51540924 | Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting. |
| Q33492143 | Bayesian design using adult data to augment pediatric trials |
| Q90173489 | Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes |
| Q35057399 | Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials |
| Q36381197 | Bayesian methods for evidence synthesis in cost-effectiveness analysis |
| Q39787888 | Bayesian models for subgroup analysis in clinical trials. |
| Q38931091 | Bayesian population finding with biomarkers in a randomized clinical trial |
| Q47938024 | Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment |
| Q37127305 | Costs and effectiveness of the fast track intervention for antisocial behavior |
| Q36571625 | Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? |
| Q46156087 | Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome |
| Q36746642 | Estimation of treatment effect in a subpopulation: An empirical Bayes approach |
| Q35599801 | Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach |
| Q48007302 | Experience with reviewing Bayesian medical device trials |
| Q30445406 | Genetics of adverse reactions to haloperidol in a mouse diallel: a drug-placebo experiment and Bayesian causal analysis. |
| Q38659774 | Hierarchical Bayes approach for subgroup analysis |
| Q38893573 | Identification of predicted individual treatment effects in randomized clinical trials |
| Q28086970 | Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review |
| Q39115873 | Model averaging for treatment effect estimation in subgroups |
| Q36482037 | On Bayesian methods of exploring qualitative interactions for targeted treatment. |
| Q38546337 | QUINT: A tool to detect qualitative treatment-subgroup interactions in randomized controlled trials |
| Q35957202 | Qualitative Treatment-Subgroup Interactions in a Randomized Clinical Trial of Treatments for Adolescents with ADHD: Exploring What Cognitive-Behavioral Treatment Works for Whom |
| Q95573748 | Radiotherapy for metastatic prostate cancer |
| Q33932001 | Reading and assessing reports of treatment studies in oncology |
| Q40191478 | Robust exchangeability designs for early phase clinical trials with multiple strata |
| Q39361114 | Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems |
| Q38919048 | Subgroup finding via Bayesian additive regression trees |
| Q33981752 | Subgroup identification from randomized clinical trial data |
| Q58601718 | Subgroup identification in clinical trials via the predicted individual treatment effect |
| Q47274717 | Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer |
| Q39527439 | The influence of baseline marijuana use on treatment of cocaine dependence: application of an informative-priors bayesian approach |
| Q37579813 | Treatment effect heterogeneity for univariate subgroups in clinical trials: Shrinkage, standardization, or else |
| Q31119441 | Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials |
Search more.